Cargando…
Calcific uremic arteriolopathy: Pathophysiology, reactive oxygen species and therapeutic approaches
Calcific uremic arteriolopathy (CUA)/calciphylaxis is an important cause of morbidity and mortality in patients with chronic kidney disease requiring renal replacement. Once thought to be rare, it is being increasingly recognized and reported on a global scale. The uremic milieu predisposes to multi...
Autores principales: | Sowers, Kurt M, Hayden, Melvin R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952095/ https://www.ncbi.nlm.nih.gov/pubmed/20716935 http://dx.doi.org/10.4161/oxim.3.2.5 |
Ejemplares similares
-
Calcific uremic arteriolopathy
por: Olaoye, Olanrewaju A, et al.
Publicado: (2017) -
Vascular ossification – calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis – calcific uremic arteriolopathy: the emerging role of sodium thiosulfate
por: Hayden, Melvin R, et al.
Publicado: (2005) -
Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations
por: New, Nicholas, et al.
Publicado: (2011) -
Elastic fiber alterations and calcifications in calcific uremic arteriolopathy
por: Colboc, Hester, et al.
Publicado: (2023) -
Multi-intervention management of calcific uremic arteriolopathy in 24 patients
por: Harris, Claire, et al.
Publicado: (2018)